ADA

June 16, 2020

New data released today from the Diabetes Prevention Program Outcomes Study (DPPOS) shows that in over 2000 patients followed for an average of 22 years, lifestyle programs and treatment with metformin continues to prevent the development of type 2 diabetes in at risk populations.

June 15, 2020

New data from the Environmental Determinants of Diabetes in the Young (TEDDY) study illuminate the environmental triggers that are thought to cause the autoimmune response leading to type 1 diabetes(T1D) and celiac disease. The data was presented in a symposium at the American Diabetes Association meeting.

July 20, 2016

Follow-up data from the landmark Diabetes Prevention Study examined the role of physical activity in diabetes prevention.

July 12, 2016

This slideshow highlights several studies regarding the effects of SGLT2 inhibitors, which were presented at the 2016 ADA Scientific Sessions.

July 01, 2016

Several studies presented at ADA 2016 discussed going beyond basal insulin treatments for patients with type 2 diabetes.

June 16, 2016

A secondary analysis of data from the Insulin Resistance Intervention after Stroke trial (IRIS) examined pioglitazone’s effect on diabetes prevention.

June 15, 2016

The first at-home study to test the efficacy & safety of a fully automated, dual hormone (glucagon and insulin) bionic pancreas was presented at ADA.

June 14, 2016

A study tested the impact of intensive lifestyle intervention in low-income African Americans with type 2 diabetes. Results were shared at ADA.

June 13, 2016

A post hoc analysis delved further into the EXAMINE trial to evaluate the risk of cardiovascular death in all of the type 2 diabetic participants.

June 12, 2016

Is health-related quality of life as important as a patient’s A1c? Presentations at the 2016 ADA meeting discussed this component of diabetes care.